Genomictree Inc. (KOSDAQ:228760)
South Korea flag South Korea · Delayed Price · Currency is KRW
12,090
+290 (2.46%)
Jun 10, 2026, 3:30 PM KST

Genomictree Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
8,72116,31526,35045,26967,57266,461
Short-Term Investments
66,66461,05169,73047,87747,03364,081
Cash & Short-Term Investments
75,38577,36696,08093,146114,605130,542
Cash Growth
-19.79%-19.48%3.15%-18.72%-12.21%26.59%
Accounts Receivable
234.45384.04332.5388.291,0312,267
Other Receivables
402.88273.45274.54286.19144.1128.22
Receivables
637.33657.49607.04674.471,1752,295
Inventory
328.5265.3334.58496.53635.45284.87
Prepaid Expenses
114.642.24105.9395.89424.22502.98
Other Current Assets
679.82574.12534.92657.951,160702.45
Total Current Assets
77,14578,90597,66295,371118,000134,327
Property, Plant & Equipment
20,08919,85818,38617,46017,86621,459
Long-Term Investments
20,56114,2316,43014,04821,13619,656
Other Intangible Assets
1,3121,2411,2501,3361,4701,523
Long-Term Deferred Charges
00020.9283.67146.43
Other Long-Term Assets
6,8656,5266,9474,6084,35440.12
Total Assets
125,973120,762130,675132,844162,910177,151
Accounts Payable
156.7676.8966.8966.79132.687.57
Accrued Expenses
667.481,4981,4451,4331,821441.27
Short-Term Debt
-2,3011,9721,69029,043-
Current Portion of Long-Term Debt
--0000-
Current Portion of Leases
37.1641.3247.4247.4252.8265.79
Current Income Taxes Payable
----1.7-
Current Unearned Revenue
-2.011.030.649.828.6
Other Current Liabilities
494.83524.591,2182,04422,3811,319
Total Current Liabilities
1,3564,4454,7515,28153,4422,142
Long-Term Debt
-----37,271
Long-Term Leases
18.0324.8159.9897.5284.63907.61
Pension & Post-Retirement Benefits
996.44854.71,4182,2901,2022,754
Long-Term Deferred Tax Liabilities
103.3103.392.9792.97579.61206.6
Other Long-Term Liabilities
2624.5533.7849.9444.3918,770
Total Liabilities
2,5005,4526,3567,81255,35362,050
Common Stock
12,43012,19112,18112,00610,51310,164
Additional Paid-In Capital
94,24586,31685,93579,97257,05055,819
Retained Earnings
10,08812,03720,60231,27439,97646,434
Treasury Stock
-4,359-4,714-4,878-4,984-4,984-
Comprehensive Income & Other
10,7639,23910,0456,4684,3452,296
Total Common Equity
123,166115,070123,885124,736106,900114,713
Minority Interest
307.19239.96434.79295.48502.28-
Shareholders' Equity
123,473115,310124,320125,032107,557115,101
Total Liabilities & Equity
125,973120,762130,675132,844162,910177,151
Total Debt
55.192,3682,0791,83529,18038,444
Net Cash (Debt)
75,33074,99894,00191,31285,42592,098
Net Cash Growth
-17.98%-20.21%2.94%6.89%-7.25%0.57%
Net Cash Per Share
3127.563123.843937.193444.884069.684461.03
Filing Date Shares Outstanding
24.3724.0223.9923.6320.6520.33
Total Common Shares Outstanding
24.3724.0223.9923.6320.6520.33
Working Capital
75,78974,46092,91290,09064,557132,185
Book Value Per Share
5053.894790.105163.995278.295177.785643.25
Tangible Book Value
121,854113,829122,635123,400105,429113,190
Tangible Book Value Per Share
5000.064738.455111.895221.765106.575568.33
Land
8,0127,8557,6997,9817,9249,612
Buildings
5,8045,6225,7036,1676,1008,064
Machinery
11,12310,9468,7756,1026,0164,524
Construction In Progress
398.11326.11363.59326.11133.2138.2